Examorelin
Also known as: Hexarelin Analog, EP51389, Examorelin Acetate
Examorelin is a synthetic growth hormone-releasing peptide (GHRP) that stimulates growth hormone secretion through ghrelin receptor activation. This hexapeptide analog demonstrates potent GH-releasing activity with potential applications in growth hormone deficiency research.
Examorelin is a 887.05 g/mol research peptide. Examorelin is a synthetic growth hormone-releasing peptide (GHRP) that stimulates growth hormone secretion through ghrelin receptor activation. This hexapeptide analog demonstrates potent GH-releasing activity with potential applications in growth hormone deficiency research.
Also called: Hexarelin Analog, EP51389, Examorelin Acetate
887.05 g/mol
Molecular Weight
Daltons
1
Strong Evidence
benefits
4
Studies Cited
peer-reviewed
0.5-2
Typical Dose
mg
Overview
Examorelin belongs to the family of growth hormone-releasing peptides, functioning as a selective ghrelin receptor agonist. The peptide triggers endogenous growth hormone release from the anterior pituitary gland by binding to growth hormone secretagogue receptors (GHS-R). Unlike continuous GH administration, Examorelin preserves the natural pulsatile pattern of growth hormone secretion, maintaining physiological feedback mechanisms. Research indicates this peptide may offer advantages in studying growth hormone dynamics, body composition changes, and metabolic regulation. The compound's structure allows for enhanced stability compared to natural GHRH while maintaining high receptor selectivity.
Key Takeaways: Examorelin
- Strongest evidence supports Examorelin for growth hormone stimulation
- Research doses typically range from 0.5 to 2 mg via subcutaneous
- 1 benefits with strong evidence, 2 moderate, 3 preliminary
- Half-life: 30-60 minutes
- 4 cited research studies in this guide
Mechanism of Action
Examorelin binds to growth hormone secretagogue receptors (GHS-R1a) in the hypothalamus and pituitary gland, triggering calcium influx and cAMP elevation. This activation stimulates growth hormone-releasing hormone (GHRH) release from the hypothalamus and directly promotes GH secretion from somatotroph cells in the anterior pituitary. The peptide also influences IGF-1 production in the liver and peripheral tissues, creating a cascade of anabolic and metabolic effects.
Research Benefits
Examorelin at a Glance
Examorelin binds to growth hormone secretagogue receptors (GHS-R1a) in the hypothalamus and pituitary gland, triggering calcium influx and cAMP elevation.
Growth Hormone Stimulation
Strong EvidenceExamorelin potently stimulates endogenous GH release through ghrelin receptor activation, maintaining natural pulsatile secretion patterns while achieving significant increases in circulating GH levels.
Body Composition Research
Moderate EvidenceStudies demonstrate Examorelin's ability to promote lean mass gains and reduce adipose tissue through enhanced protein synthesis and lipolytic activity mediated by GH/IGF-1 axis activation.
Metabolic Enhancement
Moderate EvidenceThe peptide improves glucose metabolism and insulin sensitivity through GH-mediated effects on hepatic glucose production and peripheral tissue glucose uptake mechanisms.
Bone Density Support
PreliminaryResearch indicates Examorelin may enhance bone formation markers and mineral density through IGF-1 stimulation of osteoblast activity and collagen synthesis.
Sleep Quality Improvement
PreliminaryThe peptide influences sleep architecture by enhancing slow-wave sleep phases, which correlates with natural GH secretion patterns and recovery processes.
Cardiovascular Function
PreliminaryExamorelin shows potential cardioprotective effects through GH-mediated improvements in cardiac output, vascular function, and myocardial protection mechanisms.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| GH stimulation research | 0.5–2 mg | subcutaneous |
| Body composition studies | 1–3 mg | subcutaneous |
| Metabolic research | 0.5–1.5 mg | subcutaneous |
Frequency
Once daily, preferably before bedtime
Timing
Evening administration aligns with natural GH secretion patterns
Cycle Length
4-8 week research periods with 2-4 week breaks
Research Notes
- 1Administer on empty stomach for optimal absorption
- 2Avoid food intake 2 hours before and 1 hour after administration
- 3Research protocols typically involve 5 days on, 2 days off patterns
- 4Monitor for desensitization with extended use
Reconstitution Guide
Standard Reconstitution
Vial Size
2 mg
Bacteriostatic Water
2 mL
Concentration
10 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Examorelin vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C refrigerated. 4 weeks when reconstituted.
Storage Temperature
2-8°C refrigerated
Shelf Life
4 weeks when reconstituted
Important Notes
- •Use bacteriostatic water for multi-dose vials
- •Inject water slowly down the side of the vial
- •Gentle swirling motion, avoid vigorous shaking
- •Clear solution indicates proper reconstitution
- •Protect from direct light exposure
Examorelin Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Examorelin Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Increased hunger and appetite stimulation
- !Water retention and mild edema
- !Joint discomfort or stiffness
- !Numbness or tingling in extremities
- !Fatigue and drowsiness
- !Headaches and dizziness
- !Nausea and gastrointestinal upset
- !Injection site reactions
- !Cortisol level alterations
- !Prolactin elevation
Potential Interactions
- ⚡Insulin and glucose-lowering medications may require adjustment
- ⚡Corticosteroids may reduce GH-releasing effects
- ⚡Thyroid hormones can influence GH sensitivity
- ⚡Growth hormone therapy creates additive effects
- ⚡Beta-blockers may alter cardiovascular responses
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Growth hormone-releasing activity of examorelin in healthy subjects
Clinical study demonstrating Examorelin's potent GH-releasing effects with dose-dependent responses in healthy volunteers.
Metabolic effects of growth hormone secretagogues in obesity research
Research examining Examorelin's influence on body composition and metabolic parameters in overweight subjects.
Cardiovascular effects of ghrelin receptor agonists
Study investigating the cardioprotective potential of GHRP analogs including Examorelin in cardiac function assessment.
Sleep-promoting effects of growth hormone secretagogues
Analysis of how GHRP compounds influence sleep architecture and slow-wave sleep enhancement in research subjects.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Examorelin is a synthetic growth hormone-releasing peptide that works by binding to ghrelin receptors in the brain and pituitary gland. This binding triggers natural growth hormone release, maintaining physiological secretion patterns while significantly increasing GH levels.
Research protocols typically use 0.5-3mg administered subcutaneously once daily, preferably in the evening on an empty stomach. Cycles usually last 4-8 weeks with periodic breaks to prevent receptor desensitization.
Common side effects include increased appetite, water retention, joint discomfort, fatigue, and injection site reactions. Some users may experience headaches, nausea, or hormonal fluctuations affecting cortisol and prolactin levels.
Examorelin has a relatively short half-life of 30-60 minutes, but its effects on growth hormone release can persist for several hours. The peptide is typically cleared from circulation within 4-6 hours of administration.
While Examorelin can potentially be combined with other research peptides, interactions with insulin-affecting compounds, growth hormone, or corticosteroids should be carefully considered. Always consult research protocols before combining substances.
Once reconstituted with bacteriostatic water, Examorelin should be stored at 2-8°C in a refrigerator, protected from light. The solution typically remains stable for up to 4 weeks when properly stored.
Yes, research suggests cycling is important to prevent receptor desensitization. Common protocols involve 4-8 week research periods followed by 2-4 week breaks, or 5 days on, 2 days off patterns.
Evening administration is preferred as it aligns with natural growth hormone secretion patterns. Taking it before bedtime on an empty stomach optimizes absorption and mimics physiological GH release cycles.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.